Andrew T. Huang

Journal article Int J Radiat Oncol Biol Phys · September 1, 2002 Featured Work PURPOSE: To analyze the correlation of radiation-induced liver disease (RILD) with patient-related and treatment-related dose-volume factors and to describe the probability of RILD by a normal tissue complication probability (NTCP) model for patients with ... Full text Link to item Cite

Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy.

Journal article Int J Radiat Oncol Biol Phys · June 1, 2002 Featured Work PURPOSE: When the primary tumor of nasopharyngeal carcinoma (NPC) is treated at the base of skull and intracranium with conventional radiotherapy, the result is generally poor. In this report, we investigated whether hyperfractionated radiotherapy (HFRT) a ... Full text Link to item Cite

Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization.

Journal article Int J Cancer · August 20, 2001 Featured Work The purpose of our study was to evaluate the outcome, patterns of failure, and toxicity for patients with unresectable hepatocellular carcinoma (HCC) treated with radiotherapy, transcatheter arterial chemoembolization (TACE), or combined TACE and radiother ... Full text Link to item Cite

Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials.

Journal article Int J Radiat Oncol Biol Phys · July 1, 2001 Featured Work PURPOSE: Concomitant chemotherapy and radiotherapy (CCRT), followed by adjuvant chemotherapy, has improved the outcome of nasopharyngeal carcinoma (NPC). However, the prognosis and patterns of failure after this combined-modality treatment are not yet clea ... Full text Link to item Cite

Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy.

Journal article Int J Radiat Oncol Biol Phys · December 1, 2000 Featured Work PURPOSE: The purpose of this study is to demonstrate long-term survival of nasopharyngeal carcinoma treated with concomitant chemotherapy and radiotherapy (CCRT) followed by adjuvant chemotherapy. METHODS AND PATIENTS: One hundred and seven patients with S ... Full text Link to item Cite

Unique features of breast cancer in Taiwan.

Journal article Breast Cancer Res Treat · October 2000 Featured Work Between April 1990 and December 1997, 811 consecutive patients with 830 newly diagnosed breast cancers having their primary treatments in our institution were included in this study. Sixty three percent of breast cancer patients were premenopausal. The ear ... Full text Link to item Cite

Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma.

Journal article J Clin Oncol · May 2000 Featured Work PURPOSE: Early-stage nasopharyngeal carcinoma (NPC) continues to carry a failure rate of 15% to 30% when treated with radiotherapy alone; the benefit of concomitant radiotherapy and chemotherapy (CCRT) in early-stage NPC is unclear. The purpose of this rep ... Full text Link to item Cite

Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.

Journal article Int J Radiat Oncol Biol Phys · May 1, 2000 Featured Work PURPOSE: To evaluate the treatment outcome, patterns of failure, and prognostic factors for patients with unresectable hepatocellular carcinoma (HCC) treated with local radiotherapy alone or as an adjunct to transcatheter arterial chemoembolization (TACE). ... Full text Link to item Cite

Adjuvant sequential chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil (ACMF) with concurrent radiotherapy in resectable advanced breast cancer.

Journal article Am J Clin Oncol · April 2000 Featured Work Doxorubicin (Adriamycin) is an anthracycline effective in breast cancer. Despite a worldwide acceptance of Adriamycin in the adjuvant chemotherapy to maximize the survival benefit in the higher risk patients with breast cancer with promising results, oncol ... Full text Link to item Cite